May 9, 2019

TB Alliance and Partners Form Multidisciplinary Center for Translational TB Drug Research

New collaboration, supported by U.S. National Institutes of Health, to produce two new clinical stage TB drug candidates
April 29, 2019

Joint Statement on Universal Health Coverage and TB Research

Moving Together to Build a Healthier World
April 25, 2019

A Conversation with Karl Hofmann

Looking back and looking forward with the outgoing president of TB Alliance's Stakeholders Association
April 18, 2019

TB Alliance and Mylan Announce Global Collaboration to Commercialize Investigational Drug Pretomanid as Part of Two Regimens to Treat Tuberculosis

Regimens under clinical development include treatment options for drug-resistant forms of TB
March 20, 2019

Statement on Building a Tuberculosis Free World: The Lancet Commission on Tuberculosis

This is an important moment to take stock of the milestones achieved in the fight against TB and to spur policymakers and funders to commit the necessary resources to end TB.
February 5, 2019

Compound Studied in TB to be Evaluated in the Treatment of Leishmaniasis

Wellcome commits £10 million to DNDi to develop new generation of oral drugs to treat leishmaniasis
January 18, 2019

Played Red Dead Redemption 2? Here’s what you should know about TB

Whether it’s 1899 or 2019, TB is a serious disease that poses a significant challenge to global health
January 15, 2019

Jan Lundberg Joins TB Alliance Board of Directors

Lundberg has more than 20 years of experience in global R&D management, including the approval of 20+ new medicines